4//SEC Filing
Hassanein Waleed H 4
Accession 0000950170-24-115332
CIK 0001756262other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:30 PM ET
Size
15.1 KB
Accession
0000950170-24-115332
Insider Transaction Report
Form 4
Hassanein Waleed H
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-10-15$131.91/sh−3,607$475,799→ 66,661 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-15−8,625→ 96,250 totalExercise: $13.28Exp: 2032-02-22→ Common Stock (8,625 underlying) - Exercise/Conversion
Common Stock
2024-10-15$13.28/sh+8,625$114,540→ 70,268 total - Sale
Common Stock
2024-10-15$135.04/sh−300$40,512→ 61,643 total - Sale
Common Stock
2024-10-15$132.82/sh−3,518$467,261→ 63,143 total - Sale
Common Stock
2024-10-15$134.23/sh−1,200$161,076→ 61,943 total
Holdings
- 469,359(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $131.29 to $132.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $132.34 to $133.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $133.57 to $134.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $134.63 to $135.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001430466
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:30 PM ET
- Size
- 15.1 KB